Caxton Associates (UK)’s AMERISAFE AMSF Stock Holding History

Caxton Associates (UK)’s Portfolio AMSF Stock Details AMSF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,237	Closed	-$316K	–	693
2025 Q2	$316K	Buy	+7,237	New	+$341K	0.01%	528

Other funds holding AMSF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caxton Associates (UK)'s AMSF Position: Q3 2025 in Review

Caxton Associates (UK) sold out of AMERISAFE (AMSF) in Q3 2025, closing a stake of 7,237 shares — an estimated $316K sold.

Caxton Associates (UK) first reported a position in AMSF in Q2 2025 and held it in 1 quarter. The position peaked at $316K in Q2 2025. 196 funds tracked by Wall St. Rank hold AMSF as of Q3 2025.

Caxton Associates (UK) reported no remaining AMERISAFE position as of Q3 2025 after selling out during the quarter.
Caxton Associates (UK) sold 7,237 AMERISAFE shares in Q3 2025, an estimated $316K.
Caxton Associates (UK) first reported a position in AMERISAFE in Q2 2025 and held it in 1 quarter.
Caxton Associates (UK)'s AMERISAFE position peaked at $316K in Q2 2025.
196 funds tracked by Wall St. Rank held AMERISAFE as of Q3 2025.

Based on Caxton Associates (UK)'s 13F filing for Q3 2025, filed 17 Nov 2025.